Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Vitamin D Review Shows No Consensus On Optimum Levels For Bone Health

This article was originally published in The Tan Sheet

Executive Summary

A review of vitamin D studies reflects uncertainty among researchers concerning how much of the vitamin is needed for optimal bone health and about differences in the relationship between vitamin D and bone health across age groups and life stages, the National Institutes of Health's Office of Dietary Supplements says

You may also be interested in...



Report Links Vitamin D3 To Cancer Prevention, Calls For Replacing D2

A report linking vitamin D3 with decreased cancer risk calls for the supplement and nutrition industries to use vitamin D3 rather than vitamin D2 in their products, which could create challenges for manufacturers, industry sources observe

Report Links Vitamin D3 To Cancer Prevention, Calls For Replacing D2

A report linking vitamin D3 with decreased cancer risk calls for the supplement and nutrition industries to use vitamin D3 rather than vitamin D2 in their products, which could create challenges for manufacturers, industry sources observe

Report Links Vitamin D3 To Cancer Prevention, Calls For Replacing D2

A report linking vitamin D3 with decreased cancer risk calls for the supplement and nutrition industries to use vitamin D3 rather than vitamin D2 in their products, which could create challenges for manufacturers, industry sources observe

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS100853

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel